Models

Dataset Information

0

Stokes2020 - Antibiotics discovery using deep learning approach.


ABSTRACT: Based on a simple E.coli growth inhibition assay, the authors trained a model capable of identifying antibiotic potential in compounds structurally divergent from conventional antibiotic drugs. One of the predicted active molecules, Halicin (SU3327), was experimentally validated in vitro and in vivo. Model Type: Predictive machine learning model. Model Relevance: Probability that a compound inhibits E.coli growth. Model Encoded by: Miquel Duran-Frigola(Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos4e40

SUBMITTER: Zainab Ashimiyu-Abdusalam  

PROVIDER: MODEL2404080001 | BioModels | 2024-04-22

REPOSITORIES: BioModels

Dataset's files

Source:
Action DRS
MODEL2404080001?filename=BioModelsMetadata%20-%20eos4e40.csv Csv
Items per page:
1 - 1 of 1
altmetric image

Publications


Due to the rapid emergence of antibiotic-resistant bacteria, there is a growing need to discover new antibiotics. To address this challenge, we trained a deep neural network capable of predicting molecules with antibacterial activity. We performed predictions on multiple chemical libraries and discovered a molecule from the Drug Repurposing Hub-halicin-that is structurally divergent from conventional antibiotics and displays bactericidal activity against a wide phylogenetic spectrum of pathogens  ...[more]

Similar Datasets

2024-06-03 | MODEL2406030003 | BioModels
2024-05-08 | MODEL2405080006 | BioModels
2024-05-28 | MODEL2405080001 | BioModels
2024-05-21 | MODEL2405210005 | BioModels
2024-07-18 | MODEL2406270007 | BioModels
2024-05-13 | MODEL2403270001 | BioModels
2024-06-03 | MODEL2406030002 | BioModels
2024-05-21 | MODEL2405210004 | BioModels
2024-07-18 | MODEL2407180003 | BioModels
2024-07-18 | MODEL2407180004 | BioModels